Han Xu, M.d., Ph.d., Fapcr, Sponsor-investigator, Irb Chair

This early-phase study tests a new biologic treatment in 20 HIV-positive adults without AIDS symptoms. The goal is to see if the therapy can lower the amount of virus in the blood and help the immune system better target HIV. While promising, this is a proof-of-concept trial and …

This study looks at how small genetic differences (SNPs) in certain genes affect how well the drug raloxifene works and its side effects in people with a type of early breast cancer called LCIS. Researchers will analyze DNA from 600 participants to find gene patterns linked to be…

This study looks at how tiny differences in your DNA (called SNPs) might influence how well the drug alectinib works against non-small cell lung cancer, and whether it causes side effects. Researchers will analyze blood samples from 600 patients to find genetic markers linked to …

This study looks at how small differences in genes (called SNPs) affect how well the drug topotecan works and its side effects in people with small cell lung cancer. Researchers will test 600 patients who are already taking topotecan to find gene patterns linked to better outcome…